Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
34.54
-2.75 (-7.37%)
At close: Sep 23, 2026, 4:00 PM EDT
34.54
0.00 (0.00%)
After-hours: Sep 23, 2026, 4:10 PM EDT
Immunovant Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Immunovant stock has a consensus rating of "Buy" and an average price target of $48.88. The average 1-year stock price forecast is 41.52% higher than the current stock price, while the lowest is $30 (-13.14%) and the highest is $66 (+91.08%).
Price Target: $48.88 (+41.52%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immunovant stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 10 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 5 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 18 | 17 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $41 | Buy | Maintains | $41 | +18.70% | Sep 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $53 | Buy | Maintains | $53 | +53.45% | Sep 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +91.08% | Sep 21, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Reiterates $24 → $40 | Hold | Reiterates | $24 → $40 | +15.81% | Aug 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $49 → $57 | Buy | Maintains | $49 → $57 | +65.03% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
36.81M
EPS This Year
-2.84
from -2.47
EPS Next Year
-2.75
from -2.84
EPS and Forward PE are based on non-GAAP adjusted numbers.